Search by Drug Name or NDC
NDC 00023-3919-51 BOTOX Cosmetic 50 [USP'U]/1 Details
BOTOX Cosmetic 50 [USP'U]/1
BOTOX Cosmetic is a INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is BOTULINUM TOXIN TYPE A.
Product Information
| NDC | 00023-3919 |
|---|---|
| Product ID | 0023-3919_55da57ed-9beb-4476-abf1-36cb380ac17f |
| Associated GPIs | 90890020002110 |
| GCN Sequence Number | 060526 |
| GCN Sequence Number Description | onabotulinumtoxinA VIAL 50 UNIT INTRAMUSC |
| HIC3 | S7H |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS (COSMETIC) |
| GCN | 26700 |
| HICL Sequence Number | 004867 |
| HICL Sequence Number Description | ONABOTULINUMTOXINA |
| Brand/Generic | Brand |
| Proprietary Name | BOTOX Cosmetic |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | onabotulinumtoxinA |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | [USP'U]/1 |
| Substance Name | BOTULINUM TOXIN TYPE A |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103000 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00023-3919-51 (00023391951)
| NDC Package Code | 0023-3919-51 |
|---|---|
| Billing NDC | 00023391951 |
| Package | 1 VIAL, GLASS in 1 CARTON (0023-3919-51) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
| Marketing Start Date | 2008-07-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |